Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases

Table 2

Multivariate Cox proportional hazards model for waitlist survival.

	HR	95% CI	value
Age	1.04	1.04–1.05	<0.001
Gender (female)	0.75	0.63–0.89	0.001
Presence of HCC	1.38	0.92–2.06	0.114
Initial MELD	1.17	1.16–1.18	<0.001
No college education	1.04	0.88–1.24	0.577
Payment source
Private	Ref
Public	1.54	1.30–1.83	<0.001
Other	1.36	0.50–3.68	0.543
ABO group
A	Ref
B	0.80	0.59–1.06	0.131
AB	1.47	0.92–2.37	0.103
O	0.94	0.79–1.12	0.528
UNOS region
1	Ref
2	0.93	0.63–1.39	0.753
3	0.63	0.41–0.96	0.032
4	1	0.66–1.50	0.993
5	0.62	0.41–0.94	0.025
6	0.69	0.41–1.17	0.176
7	0.70	0.47–1.05	0.092
8	0.95	0.62–1.44	0.824
9	0.71	0.45–1.11	0.143
10	1.13	0.76–1.68	0.535
11	0.81	0.53–1.22	0.320
African Americans	1.28	1.02–1.59	0.028

MELD, model for end-stage liver disease. HCC, hepatocellular carcinoma. HR, hazard ratio. CI, confidence interval. REF, reference.